N-of-One can provide valuable, relevant evidence for any molecular diagnostic test result, at any scale

N-of-One can provide valuable, relevant evidence for any molecular diagnostic test result, at any scale

Hospital Laboratories

A growing number of hospitals are looking to perform molecular diagnostic testing in-house to support their growing precision medicine programs. With decreasing costs of diagnostics platforms and an expanding number of bioinformatics tools, this is now possible.

The remaining challenge is how to annotate test results with the relevant research and clinical evidence physicians need at the point of care. N-of-One solutions allow hospital molecular labs to leverage N-of-One’s expertise and scalability to support and enrich molecular test results with clear and concise evidence.

Identifying Relevant Patient-Specific Therapeutic Options

Analyzing molecular data in a patient-specific manner is a time-consuming task. The time and resources required to research, synthesize and tailor the clinical and scientific evidence for each molecular profile in order to develop potential treatment strategies requires a large, highly skilled and experienced team. This cannot be achieved with a software algorithm.

Staying Up-to-Date

There are hundreds of targeted oncology therapies in development. New research on oncology therapeutics is published every day. As a result, it’s simply impossible for pathologists to keep up with even the major developments in the field that may impact a test result.

Molecular Test Volume Growth

As precision medicine moves into the mainstream, laboratories expect their molecular test volume to increase. In order to meet increasing demand, labs need the ability to scale and deliver results faster than ever before. But delivering high quality, meaningful molecular test results rapidly can be expensive.

Solutions

N-of-One provides valuable, relevant evidence for any molecular diagnostic test result, including next generation sequencing of solid and hematological tumors, circulating tumor cells and DNA, copy number analysis, and immunohistochemistry.

N-of-One solutions deliver fast and cost-effective results that seamlessly communicate with lab systems and can be scaled to meet any need—even if that means thousands of reports every month.

BACK TO
TOP
LEARN
MORE